Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CD44 | P16070 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8387574 | 1.00 | GABRA1 (0.48) | GABRA1GABRB2CYP2A6CYP1A2ACHE | |
| SCHEMBL1927917 | 0.84 | GABRA1 (0.58) | GABRA1GABRB2CYP2A6CYP1A2ACHE | |
| SCHEMBL803441 | 0.82 | ACHE (0.50) | GABRA1GABRB2CYP2A6CYP1A2ACHE | |
| SCHEMBL20807004 | 0.82 | GABRA1 (0.40) | GABRA1GABRB2CYP2A6CYP1A2ACHE | |
| SCHEMBL4446455 | 0.82 | GABRA1 (0.40) | GABRA1GABRB2CYP2A6CYP1A2ACHE | |
| SCHEMBL112587 | 0.82 | TRPA1 (0.58) | GABRA1GABRB2CYP2A6CYP1A2ACHE | |
| SCHEMBL9607578 | 0.82 | CD44 (0.52) | GABRA1GABRB2CYP2A6CYP1A2ACHE | |
| SCHEMBL803041 | 0.82 | GABRA1 (0.40) | GABRA1GABRB2CYP2A6CYP1A2ACHE | |
| SCHEMBL13487572 | 0.82 | GABRA1 (0.40) | GABRA1GABRB2CYP2A6CYP1A2ACHE | |
| SCHEMBL4446282 | 0.82 | GABRA1 (0.40) | GABRA1GABRB2CYP2A6CYP1A2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113024381-A | Preparation method of musk ketone | 辽宁东大光明化工科技有限责任公司 | 2021-06-25 | — | — | CN | claimed |
| EP-2451767-B1 | METHOD FOR PRODUCING (2,4-DIMETHYLBIPHENYL-3-YL) ACETIC ACIDS, ESTERS THEREOF AND INTERCONNECTIONS | BAYER CROPSCIENCE AG (DE) | 2019-08-21 | — | — | EP | claimed |
| CN-109400434-A | A method of 5- tert-butyl meta-xylene is prepared using tubular reactor | 濮阳市欧亚化工科技有限公司 | 2019-03-01 | — | — | CN | claimed |
| EP-1716604-B1 | SOLUTIONS OF ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2017-07-26 | — | — | EP | claimed |
| CN-102471215-B | Process for preparing (2, 4-dimethylbiphenyl-3-yl) acetic acid, esters thereof and intermediate compounds | BAYER CROPSCIENCE AG | 2014-06-11 | — | — | CN | claimed |
| US-8664428-B2 | Method for producing (2,4-dimethylbiphenyl-3-yl)acetic acids, the esters thereof and intermediate compounds | BAYER CROPSCIENCE AG (DE) | 2014-03-04 | — | — | US | claimed |
| US-20120116118-A1 | Method for Producing (2,4-Dimethylbiphenyl-3-yl)Acetic Acids, the Esters Thereof and Intermediate Compounds | BAYER CROPSCIENCE AG (DE) | 2012-05-10 | — | — | US | claimed |
| US-7820077-B2 | Solutions of organic semiconductors | MERCK PATENT GMBH (DE) | 2010-10-26 | — | — | US | claimed |
| US-20070173578-A1 | Solutions of organic semiconductors | MERCK PATENT GMBH (DE) | 2007-07-26 | — | — | US | claimed |
| EP-1716604-A1 | SOLUTIONS OF ORGANIC SEMICONDUCTORS | Merck Patent GmbH (DE) | 2006-11-02 | — | — | EP | claimed |
| WO-2005083814-A1 | SOLUTIONS OF ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2005-09-09 | — | — | WO | claimed |
| US-4255356-A | Purification of tertiary amines using an adsorbent | CHEMISCHE WERKE HULS AG (DE) | 1981-03-10 | — | — | US | claimed |
| EP-3850680-B1 | ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-11-06 | — | — | EP | disclosed |
| EP-3850679-B1 | ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-10-09 | — | — | EP | disclosed |
| US-11778904-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-10-03 | — | — | US | disclosed |
| CN-116162184-A | Iodonium salt photoinitiator and application thereof in preparing treatment-free CTP thermal printing plate | 中国乐凯集团有限公司 | 2023-05-26 | — | — | CN | disclosed |
| US-4254092-A | Method for separating hydrogen chloride and hydrogen bromide | CHEMISCHE WERKE HULS AG (DE) | 1981-03-03 | — | — | US | disclosed |
| EP-0008611-A1 | Process for the recovery of gaseous hydrogen chloride from dilute aqueous hydrochloric acid | CHEMISCHE WERKE HÜLS AG (DE) | 1980-03-19 | — | — | EP | disclosed |
| EP-0008330-A1 | Process for the separation of hydrogen chloride and hydrogen bromine | CHEMISCHE WERKE HÜLS AG (DE) | 1980-03-05 | — | — | EP | disclosed |
| EP-0007983-A1 | Process for the purification of tertiary amines | CHEMISCHE WERKE HÜLS AG (DE) | 1980-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120116118-A1 | Method for Producing (2,4-Dimethylbiphenyl-3-yl)Acetic Acids, the Esters Thereof and Intermediate Compounds | DDC, DDT, PAH | GABRA1 342/4885GABRB2 556/4885CYP2A6 82/4885 |
| US-11778904-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, SLCO1B3, NDUFV3 | GABRA1 3064/4885GABRB2 2095/4885CYP2A6 619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.